Benzinga's Top Initiations - Argent Mid Cap ETF (NASDAQ:AMID), Bellerophon Therapeutics (OTC:BLPH)

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

Analysts at SunTrust Robinson Humphrey initiated coverage on Bellerophon Therapeutics LLC

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

(NASDAQ: BLPH) with a Buy rating. The target price for Bellerophon Therapeutics is set to $23. Bellerophon Therapeutics' shares closed at $9.75 on Friday.Analysts at Sterne Agee initiated coverage on Hanesbrands Inc. (NYSE: HBI) with a Buy rating. The target price for Hanesbrands is set to $38. Hanesbrands' shares closed at $32.61 on Friday.Nomura initiated coverage on Inotek Pharmaceuticals Corporation

(NASDAQ: ITEK) with a Buy rating. The target price for Inotek Pharmaceuticals is set to $13. Inotek Pharmaceuticals' shares closed at $5.69 on Friday.Analysts at UBS initiated coverage on American Midstream Partners, LP (NYSE: AMID) with a Neutral rating. The target price for American Midstream is set to $18. American Midstream's shares closed at $17.52 on Friday.